Bio-Rad Laboratories, Inc. (NYSE:BIO)

CAPS Rating: 5 out of 5

The Company manufactures and supplies the life science research, healthcare, analytical chemistry, and other markets with products and systems used to separate chemical and biological materials, and to identify analyze and purify their components.

BIO News and Commentary

Caps

How do you think BIO will perform against the market?

Add Stock to CAPS Watchlist

All Players

193 Outperform
9 Underperform
 

All-Star Players

46 Outperform
1 Underperform
 

Wall Street

7 Outperform
0 Underperform
 

Top BIO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

kayceygirl (47.70)
Submitted August 14, 2010

This is one of my STARZ.Here is the thought process on this STAR: a) Divided rate over Zerob) 3 Year Beta between -5 & +3c) 15% + Insider ownershipd) No greater than -50% Growth rate for the last 3 years (tought= last couple of years so goo that… More

nau99 (28.36)
Submitted March 11, 2007

Cut in earnings leaves the stock worth $50-60. This one still has further to fall.

BIO VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about BIO.

Recs

0
Member Avatar RowdyCat (45.95) Submitted: 10/24/2017 4:58:22 PM : Outperform Start Price: $222.31 BIO Score: +14.27

Bio-Rad supplies molecular biology and biochemistry laboratories across the country with everyday essentials. Without Bio-Rad, much of the work conducted could not be completed.

Recs

0
Member Avatar TMFDeej (98.38) Submitted: 12/1/2016 3:52:18 PM : Outperform Start Price: $174.29 BIO Score: +29.10

Here's an interesting article on this week's Robin Hood Investor Conference that includes summaries on some of the presenters best ideas. The one that I found most interesting was from Keith Meister ofCorvex Capital:

Meister, an activist investor and a former Carl Icahn lieutenant, gave Bio-Rad Laboratories (BIO) as a long idea. He noted that it’s cheap with no analyst coverage besides Jefferies and no hedge fund ownership. The company has been implementing a new SAP system which has been costing them at the moment. Right now, the company is under-earning, trading at 7-times EBITDA versus peers trading at 14-times. He thinks the company is trading at half its intrinsic value.

Stock picks from inside this week's exclusive hedge fund conference

http://sports.yahoo.com/news/stock-picks-from-inside-this-weeks-exclusive-hedge-fund-conference-224210916.html

Jason
No positin in any company mentioned but DIS

Recs

0
Member Avatar chris293 (64.55) Submitted: 2/4/2015 6:18:16 PM : Outperform Start Price: $148.08 BIO Score: +49.53

These days with health stocks how can you lose unless crooks are running the company!

Leaderboard

Find the members with the highest scoring picks in BIO.

Score Leader

goldenginkgo

goldenginkgo (62.97) Score: +184.39

The Score Leader is the player with the highest score across all their picks in BIO.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
goldenginkgo 62.97 5/10/2007 Outperform NS $69.95 +265.25% +80.86% +184.39 0 Comment
gingerlade < 20 4/11/2007 Outperform 3M $70.39 +262.96% +88.24% +174.73 0 Comment
looanthony < 20 3/12/2007 Outperform 3W $69.14 +269.53% +94.92% +174.61 1 Comment
wunderdawg 81.48 3/8/2007 Outperform 5Y $69.51 +267.56% +94.52% +173.04 0 Comment
Bflatminor7th 26.90 3/28/2007 Outperform 3Y $70.10 +264.47% +91.78% +172.68 0 Comment
jiminica 78.67 3/5/2007 Outperform NS $69.36 +268.35% +96.82% +171.53 0 Comment
OSUChad 95.15 3/5/2007 Outperform 1Y $69.68 +266.66% +97.41% +169.26 0 Comment
Calbito 80.99 6/27/2007 Outperform 5Y $72.56 +252.11% +83.24% +168.87 0 Comment
jabs0 97.32 3/7/2007 Outperform NS $70.16 +264.15% +95.53% +168.62 0 Comment
jojosmofos 43.77 3/6/2007 Outperform 5Y $70.15 +264.21% +97.08% +167.12 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackMaximGroup 62.54 12/18/2009 Outperform NS $97.50 +162.04% +133.99% +28.05 0 Comment
TrackJefferies 83.64 11/7/2009 Outperform NS $96.90 +163.66% +142.67% +20.99 0 Comment
TrackSoleil 98.23 7/17/2009 Outperform NS $71.66 +256.53% +175.46% +81.07 0 Comment
TrackSherman 43.27 9/30/2007 Outperform NS $90.50 +182.31% +77.07% +105.24 5 Comments
TrackJohnRogers 71.70 9/30/2007 Outperform NS $90.50 +182.31% +77.07% +105.24 6 Comments
TrackSoros 87.22 9/30/2007 Outperform NS $90.50 +182.31% +77.07% +105.24 1 Comment
TrackBofASec 93.77 9/26/2007 Outperform NS $84.33 +202.96% +77.45% +125.52 0 Comment

Featured Broker Partners